SlideShare a Scribd company logo
Drugs & Medications In
Pregnancy
Tesfaye A.
( MD, Obstetrician & Gynecologist )
2/13/2023 1
Objectives
 Give overview on drug metabolism in pregnancy
 Discuss principles of teratogenicity
 Discuss risk to the fetus from some of prescription
medicines, environmental exposure & illicit drugs
2/13/2023 2
Maternal Physiology During Pregnancy
• Evolves during the course of pregnancy
CVS & Pulmonary-
Renal – increased renal plasma flow & GFR
Hepatic- higher portal venous return
GI - N &V , decreased intestinal motility
2/13/2023 3
Effect Of Physiologic Changes On Drug Metabolism
1) Drug absorption
- the slower intestinal motility and decreased gastric acid secretion
- no confirmatory evidence for increased oral bioavailability
2) Drug distribution
- decreased plasma protein ( albumin & AAG)
- increased free fraction , increased clearance
3) Drug metabolism
- Phase I & Phase II
- Activity of majority of enzymes in cytochrome P450 (CYP) system
increases during pregnancy (impacted by maternal genotype)
4) Drug Elimination
- changes in renal clearance during pregnancy varies widely
2/13/2023 4
Pharmacokinetics Of Drugs Across The
Placenta
• Placental barrier
2/13/2023 5
• Passive diffusion across the villous barrier –predominant
method of the fetus’s exposure
- Small
- lipid soluble, Cross the placenta easily
- unionized, and
- poorly protein
bound
2/13/2023 6
• Placental Transporters
- Specific endogenous substrates
2/13/2023 7
Principles Of Teratology
Teratology - the study of birth defects and their etiology
Teratogen - may be defined as any agent that act
during embryonic or fetal development
to produce a permanent alteration of
form or function.
2/13/2023 8
2/13/2023 9
Wilson’s six general
principles of teratogenesis
1. Genotype interaction with environmental factors
2. Timing of exposure
3. Mechanisms of teratogens
4. Manifestation
5. Agent
6. Dose effect
2/13/2023 10
2/13/2023 11
Fetal risks with maternal pharmacotherapy
 The overall risk of congenital malformations is 2–4%.
 However, only 10% of malformations are linked to
drug exposure
 Administration of drugs early may affect the heart or neural tube;
 Later exposure affects the formation of the ear and palate.
 Before day 31, exposure to a teratogen produces an
all-or-none effect, ( fertilization to implantation)
2/13/2023 12
Criteria To Define Teratogenicity
• Established exposure of the embryo or fetus at a critical
time during development.
• Consistent dysmorphic findings recognized in well conducted
epidemiologic studies.
• Specific defects or syndromes consistently associated with
a specific teratogen
2/13/2023 13
Studies in pregnant women
▪ Case reports or series,
- single case reports which later aggregated
- true risk posed by various drugs and environmental agents.
▪ Case-control studies,
- cases & controls are compared for exposure
▪ Cohort studies
- groups differing in exposure be followed through time,
with outcomes observed.
▪ RCTs- lacking ,unless for evaluating efficiency of prevention or treatment
2/13/2023 14
▪ Pregnancy Registries
- monitoring potentially harmful agents
- requires knowledge of the baseline prevalence
of that anomaly in the population
2/13/2023 15
Counseling for medication exposure
• Individuals tend to exaggerate potential risks associated with
medication exposure.
• The manner in which information is presented affects perception.
• Negative vs positive information
• Odds ratio vs absolute risk
2/13/2023 16
FDA classification ,
2/13/2023 17
Limitation of letter classification
- Mainly, it is for prescribing physician
- Can lead to overreliance
- higher letter grade did not necessarily mean greater risk
- drugs in the same category often had very different risks
- < 1% category A. while most had no safety data in humans ( category C)
- Does not address inadvertent exposure
2/13/2023 18
Known / Suspected teratogens
1. Alcohol
- No amount of alcohol can be considered safe in pregnancy
- Spectrum of alcohol-related fetal defects known as fetal alcohol syndrome
- CNS abnormalities,
- pre- or postnatal growth impairment, and a
- characteristic pattern of minor facial abnormalities
- In 6% of infants of heavy drinkers
2/13/2023 19
2/13/2023 20
2. Antiepileptic
• The most frequently reported anomalies are orofacial clefts, cardiac
malformations, and neural-tube defects
• valproic acid confers the greatest risk
• -The risk for fetal malformations is approximately
doubled if multiple agents are required
• Several older anticonvulsants also produce a constellation of
malformations similar to the fetal hydantoin syndrome
• The benefits of AEDs in appropriates doses during pregnancy outweigh
the risks of discontinuation.
2/13/2023 21
2/13/2023 22
•These risks do not appear to hold for the newer
agents levetiracetam and lamotrigine, although
the number of reported pregnancies to date is
smaller
•
2/13/2023 23
3. ACE inhibitors & Angiotension receptor blockers
- ACE-inhibitor fetopathy
- ACE-inhibitor embryotoxiciy??
4. Antifungals
- Fluconazole - oral clefts, abnormal facies, and cardiac, skull,
long-bone, and joint abnormalities, TOF
2/13/2023 24
5.NSAIDs
- Indomethacin – Constriction of DA,..
- ASA-
6. Leflunomide
- In several animal species, it results in fetal hydrocephalus,
eye anomalies, skeletal abnormalities, and embryo death
when given at or below human-equivalent doses
- The active metabolite, teriflunomide, is detectable in plasma for
up to 2 years following discontinuation of the medication
- What if a woman becomes pregnant while taking it ?
2/13/2023 25
7. Antimicrobials –most are safe except;
- aminoglycosides- some preterm neonates developed
ototoxicity &nephrotoxicity
- chloramphenicol - avoided in late pregnancy due to
theoretical concerns.
- Tetracyclines – are associated with yellowish-brown discoloration
of deciduous teeth when used after 25 weeks’ gestation.
2/13/2023 26
8.Antineoplastic agents
- Cyclophosphamide- high-arched palate, microcephaly, flat nasal bridge,
syndactyly, hypoplasia of the finger, secondary malignancy
- Methotrexate –conotruncal cardiac defect, facial & limb anomalies
,abortion
- Tamoxifen – DES exposure like syndrome in animals
- Trastuzumab - cases of oligohydramnios sequence resulting in pulmonary
hypoplasia, renal failure, skeletal abnormalities, and neonatal deaths have
been reported
2/13/2023 27
9. Anti virals
▪ For most ,experience in pregnancy is limited
▪ Ribavrin – causes multiple birth defects in different animal species
- skeletal , eye ,palate, GI abnormalities
- women should be on contraceptive for 6 months
after discontinuation of the drug
- contraindicated in men whose partners are pregnant.
2/13/2023 28
Efaverinz - CNS and ocular abnormalities in cynomolgus monkeys
- Antiretroviral Pregnancy Registry has identified
no increased birth defect rates in more than
800 pregnancies with first-trimester exposure
2/13/2023 29
10. Androgens- cause varying degrees of virilization and may
result in ambiguous genitalia
Danazole- There was a dose-related pattern of clitoromegaly,
fused labia, and urogenital sinus malformation.
( In a review of inadvertent exposure during early
pregnancy when given , 9-12 weeks after conception )
2/13/2023 30
11. Immunosuppressant Medications
• Corticosteroids – other vs prednisolone
• A meta-analysis of exposure to corticosteroids in the fist trimester
showed an odds ratio of 3.0 for cleft lip and/or cleft palate.
2/13/2023 31
12. Radioiodine – contraindicated in pregnancy
- Pregnancy testing should be
performed before administration
of radioiodine-131.
- no fetal risk for exposure before 12 weeks of gestation
.
2/13/2023 32
Mercury – environmental spillage
- consumption of certain species of large fish
2/13/2023 33
13. Psychiatric medications
Lithium
- has been associated with Ebstein anomaly
- These women should be offered appropriate
prenatal diagnosis with ultrasound, including
fetal echocardiography.
- may be withheld for 24 to 48 hours before
delivery to reduce both neonatal complications
2/13/2023 34
• A 1.5- to twofold greater risk for cardiac malformations
following first-trimester paroxetine exposure
• Late pregnancy exposure - neonatal behavioral syndrome , ? PPHN
• Antipsychotic – are not considered teratogenic
2/13/2023 35
14. Retinoids
- are among the most potent human teratogens
- The prevalence of birth defects after exposure
during embryogenesis is estimated to be as high as 30%
- cause abortion, CNS malformations, cardiac , facial
dysmorphism, etc.
2/13/2023 36
15.Thalidomide and Lenalidomide
- Possibly the most notorious human teratogen
- causes malformations in 20 percent of fetuses exposed between
34 and 50 days menstrual age.
- The characteristic malformation is phocomelia
- was instructive of several important teratological principles
2/13/2023 37
16. Warfarin
• Warfarin embryopathy
- nasal hypoplasia, microphthalmia ,hypoplasia of extremities ,IUGR,
cardiac defects ,deafness, mental retardation
- stippled epiphyses
• following exposure during this critical period is estimated to be 6 percent
▪ One embryopathy met analysis , warfarin dosage was ≤5 mg/d identified
in 1 percent of exposed fetuses.
▪ This suggests that risk may be dose dependent
2/13/2023 38
• Abnormalities can also include agenesis of the corpus
callosum; cerebellar vermin agenesis, which is the Dandy-Walker
malformation; microphthalmia; and optic atrophy
2/13/2023 39
17. Cocaine –
• With this CNS stimulant, most adverse outcomes result from its
vasoconstrictive and hypertensive effects
• Fetal-growth restriction and preterm delivery.
• Children exposed as fetuses have risks for behavioral abnormalities
and cognitive impairments
2/13/2023 40
Thank You
2/13/2023 41

More Related Content

Similar to Drugs & Medications In Pregnancy.pptx

acute pregnancy leukemia
acute pregnancy leukemiaacute pregnancy leukemia
acute pregnancy leukemia
Ruben Gombalandi
 
Pregnancy neurology
Pregnancy neurologyPregnancy neurology
Pregnancy neurology
srimantp
 
Teratogens
TeratogensTeratogens
Teratogens
shakshi sharma
 
Drug use in pregnany
Drug use in pregnanyDrug use in pregnany
Drug use in pregnany
Dr B Naga Raju
 
Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019
Kervindran Mohanasundaram
 
Intrauterine growth restriction
Intrauterine growth restrictionIntrauterine growth restriction
Intrauterine growth restriction
Bharti Gahtori
 
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
Võ Tá Sơn
 
Drugs use in pregnancy
Drugs use in pregnancyDrugs use in pregnancy
Drugs use in pregnancy
Vikas Sharma
 
Drugs, pregnancy, and lactation: ondansetron--troubling data.
Drugs, pregnancy, and lactation: ondansetron--troubling data.Drugs, pregnancy, and lactation: ondansetron--troubling data.
Drugs, pregnancy, and lactation: ondansetron--troubling data.
andre7black57
 
Teratogen Drugs
Teratogen DrugsTeratogen Drugs
Teratogen Drugs
Fabio Grubba
 
Epilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptxEpilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptx
Yasser Alzainy
 
Radiation protection course for radiologists L4
Radiation protection course for radiologists L4Radiation protection course for radiologists L4
Radiation protection course for radiologists L4
Amin Amin
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)
drmcbansal
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
BAPIRAJU4
 
VAriability of drug responses for 4th year.pdf
VAriability of drug responses for 4th year.pdfVAriability of drug responses for 4th year.pdf
VAriability of drug responses for 4th year.pdf
RanveerKumarVerma
 
Prenatal screening.pptx
Prenatal screening.pptxPrenatal screening.pptx
Prenatal screening.pptx
divya kumar
 
Antiprotozoal Agents Sia Salamat Et Al
Antiprotozoal Agents Sia Salamat Et AlAntiprotozoal Agents Sia Salamat Et Al
Antiprotozoal Agents Sia Salamat Et Al
guest151c
 
Drugs used in lactation and pregnacy
Drugs used in lactation and pregnacyDrugs used in lactation and pregnacy
Drugs used in lactation and pregnacy
Wezi Kaonga
 
Fighting Thalassemia; Bahrain Experience
Fighting Thalassemia; Bahrain ExperienceFighting Thalassemia; Bahrain Experience
Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,, Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,,
Jitendra Ingole
 

Similar to Drugs & Medications In Pregnancy.pptx (20)

acute pregnancy leukemia
acute pregnancy leukemiaacute pregnancy leukemia
acute pregnancy leukemia
 
Pregnancy neurology
Pregnancy neurologyPregnancy neurology
Pregnancy neurology
 
Teratogens
TeratogensTeratogens
Teratogens
 
Drug use in pregnany
Drug use in pregnanyDrug use in pregnany
Drug use in pregnany
 
Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019
 
Intrauterine growth restriction
Intrauterine growth restrictionIntrauterine growth restriction
Intrauterine growth restriction
 
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
Thai chậm tăng trưởng trong tử cung ACOG SMFM 2019
 
Drugs use in pregnancy
Drugs use in pregnancyDrugs use in pregnancy
Drugs use in pregnancy
 
Drugs, pregnancy, and lactation: ondansetron--troubling data.
Drugs, pregnancy, and lactation: ondansetron--troubling data.Drugs, pregnancy, and lactation: ondansetron--troubling data.
Drugs, pregnancy, and lactation: ondansetron--troubling data.
 
Teratogen Drugs
Teratogen DrugsTeratogen Drugs
Teratogen Drugs
 
Epilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptxEpilepsy and Pregnancy.pptx
Epilepsy and Pregnancy.pptx
 
Radiation protection course for radiologists L4
Radiation protection course for radiologists L4Radiation protection course for radiologists L4
Radiation protection course for radiologists L4
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
VAriability of drug responses for 4th year.pdf
VAriability of drug responses for 4th year.pdfVAriability of drug responses for 4th year.pdf
VAriability of drug responses for 4th year.pdf
 
Prenatal screening.pptx
Prenatal screening.pptxPrenatal screening.pptx
Prenatal screening.pptx
 
Antiprotozoal Agents Sia Salamat Et Al
Antiprotozoal Agents Sia Salamat Et AlAntiprotozoal Agents Sia Salamat Et Al
Antiprotozoal Agents Sia Salamat Et Al
 
Drugs used in lactation and pregnacy
Drugs used in lactation and pregnacyDrugs used in lactation and pregnacy
Drugs used in lactation and pregnacy
 
Fighting Thalassemia; Bahrain Experience
Fighting Thalassemia; Bahrain ExperienceFighting Thalassemia; Bahrain Experience
Fighting Thalassemia; Bahrain Experience
 
Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,, Epilepsy and pregnancy ..,,
Epilepsy and pregnancy ..,,
 

More from yilkalmossie1

IEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptxIEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptx
yilkalmossie1
 
Infection prevention and control.pptx
Infection prevention and control.pptxInfection prevention and control.pptx
Infection prevention and control.pptx
yilkalmossie1
 
Neonatal Hx and PE.pdf
Neonatal Hx and PE.pdfNeonatal Hx and PE.pdf
Neonatal Hx and PE.pdf
yilkalmossie1
 
Cyanotic Congenital Heart Diseases-C1.pptx
Cyanotic Congenital Heart Diseases-C1.pptxCyanotic Congenital Heart Diseases-C1.pptx
Cyanotic Congenital Heart Diseases-C1.pptx
yilkalmossie1
 
C1 lecture Breast complementary feeding.pptx
C1 lecture Breast complementary feeding.pptxC1 lecture Breast complementary feeding.pptx
C1 lecture Breast complementary feeding.pptx
yilkalmossie1
 
COPD.pptx
COPD.pptxCOPD.pptx
COPD.pptx
yilkalmossie1
 
Bronchial Asthma_C I medical students lecture.pptx
Bronchial Asthma_C I medical students lecture.pptxBronchial Asthma_C I medical students lecture.pptx
Bronchial Asthma_C I medical students lecture.pptx
yilkalmossie1
 
ARRYTHMIA.pptx
ARRYTHMIA.pptxARRYTHMIA.pptx
ARRYTHMIA.pptx
yilkalmossie1
 
Cardiomyopathy - lecture.ppt
Cardiomyopathy - lecture.pptCardiomyopathy - lecture.ppt
Cardiomyopathy - lecture.ppt
yilkalmossie1
 
edited.docx
edited.docxedited.docx
edited.docx
yilkalmossie1
 
Debol COVID19 (4th) edition 2012e.c (2).pdf
Debol COVID19 (4th) edition 2012e.c (2).pdfDebol COVID19 (4th) edition 2012e.c (2).pdf
Debol COVID19 (4th) edition 2012e.c (2).pdf
yilkalmossie1
 

More from yilkalmossie1 (11)

IEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptxIEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptx
 
Infection prevention and control.pptx
Infection prevention and control.pptxInfection prevention and control.pptx
Infection prevention and control.pptx
 
Neonatal Hx and PE.pdf
Neonatal Hx and PE.pdfNeonatal Hx and PE.pdf
Neonatal Hx and PE.pdf
 
Cyanotic Congenital Heart Diseases-C1.pptx
Cyanotic Congenital Heart Diseases-C1.pptxCyanotic Congenital Heart Diseases-C1.pptx
Cyanotic Congenital Heart Diseases-C1.pptx
 
C1 lecture Breast complementary feeding.pptx
C1 lecture Breast complementary feeding.pptxC1 lecture Breast complementary feeding.pptx
C1 lecture Breast complementary feeding.pptx
 
COPD.pptx
COPD.pptxCOPD.pptx
COPD.pptx
 
Bronchial Asthma_C I medical students lecture.pptx
Bronchial Asthma_C I medical students lecture.pptxBronchial Asthma_C I medical students lecture.pptx
Bronchial Asthma_C I medical students lecture.pptx
 
ARRYTHMIA.pptx
ARRYTHMIA.pptxARRYTHMIA.pptx
ARRYTHMIA.pptx
 
Cardiomyopathy - lecture.ppt
Cardiomyopathy - lecture.pptCardiomyopathy - lecture.ppt
Cardiomyopathy - lecture.ppt
 
edited.docx
edited.docxedited.docx
edited.docx
 
Debol COVID19 (4th) edition 2012e.c (2).pdf
Debol COVID19 (4th) edition 2012e.c (2).pdfDebol COVID19 (4th) edition 2012e.c (2).pdf
Debol COVID19 (4th) edition 2012e.c (2).pdf
 

Recently uploaded

The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
Isha Jaiswal
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
Vishal kr Thakur
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
R3 Stem Cell
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
smuskaan0008
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Dr. David Greene Arizona
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
nirahealhty
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
Kenneth Kruk
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
blessyjannu21
 

Recently uploaded (20)

The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareStem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac Care
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
 

Drugs & Medications In Pregnancy.pptx

  • 1. Drugs & Medications In Pregnancy Tesfaye A. ( MD, Obstetrician & Gynecologist ) 2/13/2023 1
  • 2. Objectives  Give overview on drug metabolism in pregnancy  Discuss principles of teratogenicity  Discuss risk to the fetus from some of prescription medicines, environmental exposure & illicit drugs 2/13/2023 2
  • 3. Maternal Physiology During Pregnancy • Evolves during the course of pregnancy CVS & Pulmonary- Renal – increased renal plasma flow & GFR Hepatic- higher portal venous return GI - N &V , decreased intestinal motility 2/13/2023 3
  • 4. Effect Of Physiologic Changes On Drug Metabolism 1) Drug absorption - the slower intestinal motility and decreased gastric acid secretion - no confirmatory evidence for increased oral bioavailability 2) Drug distribution - decreased plasma protein ( albumin & AAG) - increased free fraction , increased clearance 3) Drug metabolism - Phase I & Phase II - Activity of majority of enzymes in cytochrome P450 (CYP) system increases during pregnancy (impacted by maternal genotype) 4) Drug Elimination - changes in renal clearance during pregnancy varies widely 2/13/2023 4
  • 5. Pharmacokinetics Of Drugs Across The Placenta • Placental barrier 2/13/2023 5
  • 6. • Passive diffusion across the villous barrier –predominant method of the fetus’s exposure - Small - lipid soluble, Cross the placenta easily - unionized, and - poorly protein bound 2/13/2023 6
  • 7. • Placental Transporters - Specific endogenous substrates 2/13/2023 7
  • 8. Principles Of Teratology Teratology - the study of birth defects and their etiology Teratogen - may be defined as any agent that act during embryonic or fetal development to produce a permanent alteration of form or function. 2/13/2023 8
  • 10. Wilson’s six general principles of teratogenesis 1. Genotype interaction with environmental factors 2. Timing of exposure 3. Mechanisms of teratogens 4. Manifestation 5. Agent 6. Dose effect 2/13/2023 10
  • 12. Fetal risks with maternal pharmacotherapy  The overall risk of congenital malformations is 2–4%.  However, only 10% of malformations are linked to drug exposure  Administration of drugs early may affect the heart or neural tube;  Later exposure affects the formation of the ear and palate.  Before day 31, exposure to a teratogen produces an all-or-none effect, ( fertilization to implantation) 2/13/2023 12
  • 13. Criteria To Define Teratogenicity • Established exposure of the embryo or fetus at a critical time during development. • Consistent dysmorphic findings recognized in well conducted epidemiologic studies. • Specific defects or syndromes consistently associated with a specific teratogen 2/13/2023 13
  • 14. Studies in pregnant women ▪ Case reports or series, - single case reports which later aggregated - true risk posed by various drugs and environmental agents. ▪ Case-control studies, - cases & controls are compared for exposure ▪ Cohort studies - groups differing in exposure be followed through time, with outcomes observed. ▪ RCTs- lacking ,unless for evaluating efficiency of prevention or treatment 2/13/2023 14
  • 15. ▪ Pregnancy Registries - monitoring potentially harmful agents - requires knowledge of the baseline prevalence of that anomaly in the population 2/13/2023 15
  • 16. Counseling for medication exposure • Individuals tend to exaggerate potential risks associated with medication exposure. • The manner in which information is presented affects perception. • Negative vs positive information • Odds ratio vs absolute risk 2/13/2023 16
  • 18. Limitation of letter classification - Mainly, it is for prescribing physician - Can lead to overreliance - higher letter grade did not necessarily mean greater risk - drugs in the same category often had very different risks - < 1% category A. while most had no safety data in humans ( category C) - Does not address inadvertent exposure 2/13/2023 18
  • 19. Known / Suspected teratogens 1. Alcohol - No amount of alcohol can be considered safe in pregnancy - Spectrum of alcohol-related fetal defects known as fetal alcohol syndrome - CNS abnormalities, - pre- or postnatal growth impairment, and a - characteristic pattern of minor facial abnormalities - In 6% of infants of heavy drinkers 2/13/2023 19
  • 21. 2. Antiepileptic • The most frequently reported anomalies are orofacial clefts, cardiac malformations, and neural-tube defects • valproic acid confers the greatest risk • -The risk for fetal malformations is approximately doubled if multiple agents are required • Several older anticonvulsants also produce a constellation of malformations similar to the fetal hydantoin syndrome • The benefits of AEDs in appropriates doses during pregnancy outweigh the risks of discontinuation. 2/13/2023 21
  • 23. •These risks do not appear to hold for the newer agents levetiracetam and lamotrigine, although the number of reported pregnancies to date is smaller • 2/13/2023 23
  • 24. 3. ACE inhibitors & Angiotension receptor blockers - ACE-inhibitor fetopathy - ACE-inhibitor embryotoxiciy?? 4. Antifungals - Fluconazole - oral clefts, abnormal facies, and cardiac, skull, long-bone, and joint abnormalities, TOF 2/13/2023 24
  • 25. 5.NSAIDs - Indomethacin – Constriction of DA,.. - ASA- 6. Leflunomide - In several animal species, it results in fetal hydrocephalus, eye anomalies, skeletal abnormalities, and embryo death when given at or below human-equivalent doses - The active metabolite, teriflunomide, is detectable in plasma for up to 2 years following discontinuation of the medication - What if a woman becomes pregnant while taking it ? 2/13/2023 25
  • 26. 7. Antimicrobials –most are safe except; - aminoglycosides- some preterm neonates developed ototoxicity &nephrotoxicity - chloramphenicol - avoided in late pregnancy due to theoretical concerns. - Tetracyclines – are associated with yellowish-brown discoloration of deciduous teeth when used after 25 weeks’ gestation. 2/13/2023 26
  • 27. 8.Antineoplastic agents - Cyclophosphamide- high-arched palate, microcephaly, flat nasal bridge, syndactyly, hypoplasia of the finger, secondary malignancy - Methotrexate –conotruncal cardiac defect, facial & limb anomalies ,abortion - Tamoxifen – DES exposure like syndrome in animals - Trastuzumab - cases of oligohydramnios sequence resulting in pulmonary hypoplasia, renal failure, skeletal abnormalities, and neonatal deaths have been reported 2/13/2023 27
  • 28. 9. Anti virals ▪ For most ,experience in pregnancy is limited ▪ Ribavrin – causes multiple birth defects in different animal species - skeletal , eye ,palate, GI abnormalities - women should be on contraceptive for 6 months after discontinuation of the drug - contraindicated in men whose partners are pregnant. 2/13/2023 28
  • 29. Efaverinz - CNS and ocular abnormalities in cynomolgus monkeys - Antiretroviral Pregnancy Registry has identified no increased birth defect rates in more than 800 pregnancies with first-trimester exposure 2/13/2023 29
  • 30. 10. Androgens- cause varying degrees of virilization and may result in ambiguous genitalia Danazole- There was a dose-related pattern of clitoromegaly, fused labia, and urogenital sinus malformation. ( In a review of inadvertent exposure during early pregnancy when given , 9-12 weeks after conception ) 2/13/2023 30
  • 31. 11. Immunosuppressant Medications • Corticosteroids – other vs prednisolone • A meta-analysis of exposure to corticosteroids in the fist trimester showed an odds ratio of 3.0 for cleft lip and/or cleft palate. 2/13/2023 31
  • 32. 12. Radioiodine – contraindicated in pregnancy - Pregnancy testing should be performed before administration of radioiodine-131. - no fetal risk for exposure before 12 weeks of gestation . 2/13/2023 32
  • 33. Mercury – environmental spillage - consumption of certain species of large fish 2/13/2023 33
  • 34. 13. Psychiatric medications Lithium - has been associated with Ebstein anomaly - These women should be offered appropriate prenatal diagnosis with ultrasound, including fetal echocardiography. - may be withheld for 24 to 48 hours before delivery to reduce both neonatal complications 2/13/2023 34
  • 35. • A 1.5- to twofold greater risk for cardiac malformations following first-trimester paroxetine exposure • Late pregnancy exposure - neonatal behavioral syndrome , ? PPHN • Antipsychotic – are not considered teratogenic 2/13/2023 35
  • 36. 14. Retinoids - are among the most potent human teratogens - The prevalence of birth defects after exposure during embryogenesis is estimated to be as high as 30% - cause abortion, CNS malformations, cardiac , facial dysmorphism, etc. 2/13/2023 36
  • 37. 15.Thalidomide and Lenalidomide - Possibly the most notorious human teratogen - causes malformations in 20 percent of fetuses exposed between 34 and 50 days menstrual age. - The characteristic malformation is phocomelia - was instructive of several important teratological principles 2/13/2023 37
  • 38. 16. Warfarin • Warfarin embryopathy - nasal hypoplasia, microphthalmia ,hypoplasia of extremities ,IUGR, cardiac defects ,deafness, mental retardation - stippled epiphyses • following exposure during this critical period is estimated to be 6 percent ▪ One embryopathy met analysis , warfarin dosage was ≤5 mg/d identified in 1 percent of exposed fetuses. ▪ This suggests that risk may be dose dependent 2/13/2023 38
  • 39. • Abnormalities can also include agenesis of the corpus callosum; cerebellar vermin agenesis, which is the Dandy-Walker malformation; microphthalmia; and optic atrophy 2/13/2023 39
  • 40. 17. Cocaine – • With this CNS stimulant, most adverse outcomes result from its vasoconstrictive and hypertensive effects • Fetal-growth restriction and preterm delivery. • Children exposed as fetuses have risks for behavioral abnormalities and cognitive impairments 2/13/2023 40

Editor's Notes

  1. Nonetheless, studies of drugs with high rates of hepatic extraction show variable effects on their systemic availability
  2. Pharmacokinetics – what the body does on the drug
  3. Thus, a teratogen may be a medication or other chemical substance, a physical or environmental factor such as heat or radiation, a maternal metabolite as in diabetes or phenylketonuria, or an infection such as cytomegalovirus. Even obesity is considered a teratogen This can manifest either structurally or functionally [98] and malformations can vary in severity from being life threatening, to having serious cosmetic or functional consequences
  4. When teratogens are specially damaging
  5. different genetic strains of mice vary greatly in their susceptibility to teratogens that lead to oral clefts. Some of the variability in responses to antiepileptic drugs (AEDs), like valproic acid and phenytoin, probably relates to the genotype of the embryo. For example, neural tube defects (NTDs) may result from exposure between 22 and 28 days postconception. Thalidomide teratogenicity differs as a function of the developmental stage at exposure The fourth principle is that irrespective of the specifi deleterious agent, the fial manifestations of abnormal development are death, malformation, growth restriction, and/or functional disorder
  6. For example, thalidomide is harmless in several animal species but resulted in phocomelia in thousands of children born across Europe in the late 1950s and early 1960s Thalidomide, sold under the brand names Contergan and Thalomid among others, is a medication used to treat a number of cancers (including multiple myeloma), ... Shepard (2002a) recommended that establishment of teratogenicity in this way requires proven exposure at a critical time in development and probably at least three such cases, each carefully delineated.
  7. There are websites where detailed information about drugs is found.
  8. One of these anecdotes was an alleged Carthaginian law forbidding bridal couples to drink wine on their wedding night so as to avoid the conception of defective children
  9. This included a 4-percent risk for neural-tube defects (Hernandez-Diaz, 2012). School-aged children with in utero exposure to valproic acid have poorer cognitive development—including significantly lower intelligence quotient (IQ) scores—than children exposed to other antiepileptic drugs (Bromley, 2014; Meador, 2009). Valproic acid monotherapy signifiantly increases the risk for spina bifia (odds ratio [OR], 12.7), atrial septal defect (OR, 2.5), cleft palate (OR, 5.2), hypospadias (OR, 4.8), polydactyly (OR, 2.2), and craniosynostosis (OR, 6.8).16 A high daily dose or a combination of two or three of these drugs increases the chance of malformations.
  10. Phenytoin -congenital heart defects and cleft palate
  11. Effective drugs for high blood pressure & kidney disease Embryo toxicity ??although these have largely been disproven. Thus, women with inadvertent first-trimester exposure to these medications can be reassured can cause fetal renal tubular dysplasia in the second and third trimesters, leading to oligohydramnios, fetal limb contractures, craniofacial deformities, and hypoplastic lung development. Fetal skull ossifiation defects have also been described. For these reasons, women on these medications who plan pregnancy should be switched to other agents.
  12. Therefore amoxicillin/clavulanate should be avoided in women at risk for preterm delivery.
  13. Monoclonal anti human growth factor receptor 2
  14. For hep C infection
  15. TDF + 3TC+ EFV . THEN TDF+3TC+DTG
  16. Unlike other corticosteroids, the active metabolite of prednisone, which is prednisolone, is inactivated by the placental enzyme 11β-hydroxysteroid dehydrogenase 2. Thus, it may not effectively reach the fetus.
  17. Radioactive iodine (131I or 125I) administered for thyroid ablation or for diagnostic studies is not concentrated by the fetal thyroid until after 12 weeks of gestation. Thus, with inadvertent exposure before 12 weeks, there is no specifi risk to the fetal thyroid from 131I or 125I administration
  18. avoid consumption of king mackerel, marlin, orange roughy, shark, swordfish, tilefish, and bigeye tuna.
  19. American College of Obstetricians and Gynecologists (2016) recommends that paroxetine be avoided in women planning pregnancy. Fetal echocardiography should be considered for those with first-trimester paroxetine exposure.